Key Concepts & Self-Assessment20 Key Facts
Review key Extracorporeal Membrane Oxygenation (ECMO): VA-ECMO vs VV-ECMO & Critical Care Support exam facts and rate your mastery to track revision.
Progress: 0/20 Rated 0 Mastered 0 Review Later
#1
American surgeon Robert Bartlett pioneered modern extracorporeal life support in 1975, successfully utilizing prolonged membrane oxygenation to rescue a neonate experiencing meconium aspiration.
#2
The Extracorporeal Life Support Organization, founded in 1989, maintains international registries and establishes clinical standards for mechanical cardiopulmonary support in intensive care units.
#3
Extracorporeal membrane oxygenation temporarily supports gas exchange or systemic perfusion, operating as a bridge to native recovery, organ transplantation, or durable ventricular assist implantation.
#4
Veno-venous ECMO extracts blood from a large systemic vein and reinfuses oxygenated blood into the venous circulation, providing isolated respiratory gas-exchange assistance.
#5
Veno-venous cannulation requires an intact, functioning native heart because the circuit does not generate systemic arterial pressure or provide mechanical cardiac hemodynamic support.
#6
Veno-arterial ECMO withdraws deoxygenated venous blood and pumps oxygenated blood directly into a major artery, providing simultaneous biventricular circulatory and pulmonary support.
#7
Severe cardiogenic shock, post-cardiotomy failure, massive pulmonary embolism, and refractory cardiac arrest represent primary clinical indications for urgent veno-arterial ECMO cannulation.
#8
Extracorporeal cardiopulmonary resuscitation deploys veno-arterial ECMO during active cardiac arrest when conventional chest compressions fail to achieve spontaneous return of systemic circulation.
#9
Modern hollow-fiber oxygenators utilize hydrophobic polymethylpentene membranes, which provide efficient diffusion of oxygen and carbon dioxide while resisting dangerous serum plasma leakage.
#10
Sweep gas flow rate through the membrane oxygenator regulates carbon dioxide elimination, whereas the fraction of delivered oxygen governs arterial blood oxygenation.
#11
Non-occlusive centrifugal pumps generate negative drainage pressure to draw venous blood into the circuit while minimizing erythrocyte shearing and mechanical hemolysis.
#12
Systemic anticoagulation using continuous unfractionated heparin infusions prevents circuit thrombosis and is rigorously monitored using activated clotting time or anti-factor Xa assays.
#13
Ventilator-induced lung injury is minimized during ECMO by maintaining ultra-protective lung ventilation settings with low tidal volumes and reduced driving airway pressures.
#14
Harlequin syndrome, or North-South syndrome, occurs during femoral veno-arterial ECMO when poorly oxygenated native cardiac output perfuses upper extremities while ECMO perfuses lower limbs.
#15
Placing a distal arterial perfusion cannula in the superficial femoral artery prevents critical lower limb ischemia caused by large-bore arterial return cannulas.
#16
Severe bleeding complications represent the most frequent adverse event during ECMO therapy due to continuous systemic anticoagulation and acquired platelet dysfunction.
#17
Daily circuit inspections by certified perfusionists detect early fibrin deposition, micro-thrombi accumulation, and impending oxygenator failure before clinical catastrophic failure occurs.
#18
The CESAR and EOLIA clinical trials demonstrated significant survival advantages and reduced treatment failure rates for veno-venous ECMO in severe acute respiratory distress syndrome.
#19
Weaning from veno-venous ECMO involves reducing sweep gas flow to zero to assess whether the patient's recovered lungs can sustain normal carbon dioxide clearance.
#20
Decannulation from veno-arterial ECMO requires echocardiographic confirmation of adequate left ventricular ejection fraction and stable arterial hemodynamics under minimal circuit flow support.
Subject Specialist Commentary
Analytical perspective & practical exam advice from the Master10 academic board
Extracorporeal membrane oxygenation requires a clear conceptual distinction between respiratory support and hemodynamics. Examination questions regularly test the physiological divergence between VV-ECMO, which demands intact native cardiac function for lung rest, and VA-ECMO, which bypasses both cardiopulmonary circuits to treat cardiogenic shock. Candidates must understand sweep gas mechanics governing carbon dioxide clearance alongside the precise clinical indications for deploying extracorporeal cardiopulmonary resuscitation in refractory cardiac arrest scenarios.
Clinical management revolves around balancing systemic anticoagulation against catastrophic bleeding risks, monitoring polymethylpentene membrane performance, and preventing differential hypoxemia during peripheral arterial return. Recognizing unique physiological traps like Harlequin syndrome ensures prompt bedside clinical correction during intensive care therapy. To easily recall the primary operational components comprising any functioning extracorporeal life support circuit, remember the clinical engineering mnemonic PUMP: Pump, Oxygenator, Monitoring sensors, and Perfusion vascular cannulas.
Related Knowledge Topics to Discover
Looking for more GK practice?
Explore 52,789+ questions across 65 General Knowledge categories.